These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Deficiency of the insulin-like growth factor-binding protein acid-labile subunit (ALS) of the circulating ternary complex in children with short stature. Domené HM; Scaglia PA; Jasper HG Pediatr Endocrinol Rev; 2010 Jun; 7(4):339-46. PubMed ID: 20679994 [TBL] [Abstract][Full Text] [Related]
3. Acid-labile subunit deficiency: phenotypic similarities and differences between human and mouse. Domené HM; Bengolea SV; Jasper HG; Boisclair YR J Endocrinol Invest; 2005; 28(5 Suppl):43-6. PubMed ID: 16114275 [TBL] [Abstract][Full Text] [Related]
4. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency. Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728 [TBL] [Abstract][Full Text] [Related]
5. Primary acid-labile subunit deficiency due to recessive IGFALS mutations results in postnatal growth deficit associated with low circulating insulin growth factor (IGF)-I, IGF binding protein-3 levels, and hyperinsulinemia. Heath KE; Argente J; Barrios V; Pozo J; Díaz-González F; Martos-Moreno GA; Caimari M; Gracia R; Campos-Barros A J Clin Endocrinol Metab; 2008 May; 93(5):1616-24. PubMed ID: 18303074 [TBL] [Abstract][Full Text] [Related]
7. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability. Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649 [TBL] [Abstract][Full Text] [Related]
8. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P; Zwimpfer C; Zapf J; Schmid C Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465 [TBL] [Abstract][Full Text] [Related]
9. Phenotypic effects of null and haploinsufficiency of acid-labile subunit in a family with two novel IGFALS gene mutations. Domené HM; Scaglia PA; Lteif A; Mahmud FH; Kirmani S; Frystyk J; Bedecarrás P; Gutiérrez M; Jasper HG J Clin Endocrinol Metab; 2007 Nov; 92(11):4444-50. PubMed ID: 17726072 [TBL] [Abstract][Full Text] [Related]
10. Evidence that human bone cells in culture secrete insulin-like growth factor (IGF)-II and IGF binding protein-3 but not acid-labile subunit both under basal and regulated conditions. Kanzaki S; Baxter RC; Knutsen R; Baylink DJ; Mohan S J Bone Miner Res; 1995 Jun; 10(6):854-8. PubMed ID: 7572308 [TBL] [Abstract][Full Text] [Related]
11. IGF system in children with congenital disorders of glycosylation. Miller BS; Khosravi MJ; Patterson MC; Conover CA Clin Endocrinol (Oxf); 2009 Jun; 70(6):892-7. PubMed ID: 19207313 [TBL] [Abstract][Full Text] [Related]
12. The endocrine consequences for very low birth weight premature infants. Cutfield WS; Regan FA; Jackson WE; Jefferies CA; Robinson EM; Harris M; Hofman PL Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S130-5. PubMed ID: 15135795 [TBL] [Abstract][Full Text] [Related]
13. [Serum concentrations of insulin-like growth factors (IGF)-I and IGF-II and IGF binding proteins (IGFBP)-2 and IGFBP-3 in 49 children with ALL, NHL or solid tumors]. Mohnike K; Kluba U; Blum WF; Aumann V; Vorwerk P; Mittler U Klin Padiatr; 1995; 207(4):225-9. PubMed ID: 7564158 [TBL] [Abstract][Full Text] [Related]
14. Characterization of the IGF system in 15 patients with Alström syndrome. Maffei P; Boschetti M; Marshall JD; Paisey RB; Beck S; Resmini E; Collin GB; Naggert JK; Milan G; Vettor R; Minuto F; Sicolo N; Barreca A Clin Endocrinol (Oxf); 2007 Feb; 66(2):269-75. PubMed ID: 17223998 [TBL] [Abstract][Full Text] [Related]
15. The effect of epidermal growth factor on circulating levels of free and total IGF-I and IGF-binding proteins in adult rats. Frystyk J; Vinter-Jensen L; Skjaerbaek C; Flyvbjerg A Growth Regul; 1996 Mar; 6(1):48-54. PubMed ID: 8717450 [TBL] [Abstract][Full Text] [Related]
16. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients? Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646 [TBL] [Abstract][Full Text] [Related]
17. Insulin-like growth factor-I (IGF-I), insulin-like growth factor binding proteins (IGFBP) and insulin-like growth factor type I receptor in children with various status of chronic renal failure. Houang M; Cabrol S; Perin L; Ducos B; Bensman A; Le Bouc Y Growth Horm IGF Res; 2000 Dec; 10(6):332-41. PubMed ID: 11161964 [TBL] [Abstract][Full Text] [Related]
18. Three novel IGFALS gene mutations resulting in total ALS and severe circulating IGF-I/IGFBP-3 deficiency in children of different ethnic origins. Fofanova-Gambetti OV; Hwa V; Kirsch S; Pihoker C; Chiu HK; Högler W; Cohen LE; Jacobsen C; Derr MA; Rosenfeld RG Horm Res; 2009; 71(2):100-10. PubMed ID: 19129715 [TBL] [Abstract][Full Text] [Related]
19. Effects of iodine deficiency on insulin-like growth factor-I, insulin-like growth factor-binding protein-3 levels and height attainment in malnourished children. Wan Nazaimoon WM; Osman A; Wu LL; Khalid BA Clin Endocrinol (Oxf); 1996 Jul; 45(1):79-83. PubMed ID: 8796142 [TBL] [Abstract][Full Text] [Related]
20. Insulin-like growth factor (IGF)-I, -II, IGF binding proteins (IGFBP)-3, -4, and -5 levels in the conditioned media of normal human bone cells are skeletal site-dependent. Malpe R; Baylink DJ; Linkhart TA; Wergedal JE; Mohan S J Bone Miner Res; 1997 Mar; 12(3):423-30. PubMed ID: 9076585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]